ArticleInternational journal of clinical and experimental medicine2015

Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Yueming Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.